Abstract Details

Title Resumption of Antithrombotic Therapy Following Hemorrhagic Stroke in Patients with Atrial Fibrillation

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 206

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Nicholas Perros	No disclosure on file
Michael J. Schneck, MD, FAAN (Loyola University Chicago, Stritch School of Medicine)	An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
	No disclosure on file

��ɫ����